Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
This study has been completed.
Study NCT00381589   Information provided by Centre for Addiction and Mental Health
First Received: September 26, 2006   Last Updated: February 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypersalivation
Additional conditions recognized in this trial
Sialorrhea
More general conditions related to this trial
Mouth Diseases
Salivary Gland Diseases
Stomatognathic Diseases
Interventions listed in this trial
ipratropium bromide 0.03% spray
Additional drug interventions recognized in this trial
Bromides
Clozapine
Ipratropium
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anticonvulsants
Antipsychotic Agents
Autonomic Agents
Bronchodilator Agents
Central Nervous System Agents
Central Nervous System Depressants
Cholinergic Agents
Cholinergic Antagonists
GABA Agents
GABA Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Respiratory System Agents
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Centre for Addiction and Mental Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services